Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Walking a Fine Line: Safe and Effective Management of Type 2 Diabetes in Older Adults
  • CME
  • CE

Credits Available
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 contact hour (which includes 1 hour of pharmacology credit)
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: April 14, 2022 Expiration: April 13, 2023
Start Activity
Provided by the University of Cincinnati, in collaboration with ASCP and GAPNA.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Sanofi US
Derek LeRoith, MD, PhD
Program Director
Haley M. Phillippe, PharmD, BCPS, BCGP, FASCP
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify patient-specific factors that should be considered when determining individualized glycemic goals for older adults with T2D
  • Describe the efficacy and safety from clinical study results to support the use of FRC basal insulin and GLP-1 RAs in appropriate patients
  • Integrate FRC basal insulin and GLP-1 RAs into the care of appropriate patients according to guideline recommendations and patient factors/preferences
  • Detail important patient and drug considerations that can help ensure safe and effective T2D pharmacotherapy in older patients residing in LTCFs

Information on this Educational Activity

Program Director

Derek LeRoith, MD, PhD

Full Professor
Physician

Division of Endocrinology
Department of Medicine
Mount Sinai School of Medicine
Mount Sinai Hospital
New York, New York

Derek LeRoith, MD, PhD, has no relevant conflicts of interest to report.

Faculty

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES

Assistant Professor of Medicine
Diabetes Nurse Practitioner
Division of Endocrinology, Diabetes and Metabolism
Weill Cornell Medicine
New York, New York

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES, has no relevant conflicts of interest to report.
Haley M. Phillippe, PharmD, BCPS, BCGP, FASCP

Associate Clinical Professor
Pharmacy Practice
Auburn University Harrison School of Pharmacy
Ambulatory Care Clinical Pharmacist
Family Medicine, Huntsville Campus
University of Alabama at Birmingham School of Medicine
Huntsville, Alabama

Haley M. Phillippe, PharmD, BCPS, BCGP, FASCP, has no relevant conflicts of interest to report.

Staff

Courtney Duval, PharmD, BCACP
Scientific Director
Courtney Duval, PharmD, BCACP, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.
Ruth Cohen
Ruth Cohen, CHCP, has no relevant conflicts of interest to report.
The University of Cincinnati; American Society of Consultant Pharmacists; Anthony J. Jannetti, Inc. (AJJ), and the Gerontological Advanced Practice Nurses Association (GAPNA), and the peer/content reviewers for this activity have no relevant conflict of interest to report.

Target Audience

This program is intended for those HCPs who manage older patients with diabetes in both the outpatient and long-term care setting, including geriatricians, internal medicine physicians, advanced practice providers (nurse practitioners or physician assistants), and consultant pharmacists.

Goal

The goal of this activity is to improve the knowledge and competence of geriatricians, gerontological nurse practitioners, consultant and senior care pharmacists, and other HCPs regarding the management of older adults with diabetes, including those in a long-term care setting.

Accreditation

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*The American Academy of Physician Assistants accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Nursing Continuing Education

This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), and Clinical Care Options.

Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

1.0 contact hour (which includes 1 hour of pharmacology credit) will be earned by learners who successfully complete this nursing continuing professional development activity.

You must participate in at least 90% of this activity and complete the evaluation form to receive nursing continuing professional development credit.

Learning Outcome:
As a result of participating in this webinar series Providers will report an intent to change practice because of improved knowledge and competence regarding the management of older adults with diabetes.

Continuing Pharmacy Education

Credit Designation

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ASCP designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0203-9999-22-003-H01-P

Type of Activity: Application

You must participate in this activity in its entirety and complete the evaluation form to receive CPE credit. Partial credit will not be granted. Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, the course should be posted to CPE Monitor within 60 days of evaluation completion.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 14, 2022, through April 13, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Diabetes in Older Adults in LTCF: Patient and Drug Considerations
  • CME
  • CE

Loading...
Derek LeRoith, MD, PhD
Program Director
Haley M. Phillippe, PharmD, BCPS, BCGP, FASCP
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 contact hour (which includes 1 hour of pharmacology credit)
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: April 14, 2022 Expiration: April 13, 2023

Related Content

Expert commentary on healthcare transition from pediatric to adult care for patients with GHD, from Clinical Care Options (CCO)

Patience H. White, MD, MA Released: May 31, 2022

Experts discuss practical use of CGM in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)

Martin J. Abrahamson, MD, FACP
Program Director
Leslie Eiland, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credit Released: May 27, 2022 Expired: May 26, 2023

Compare current HBV vaccines and learn the best immunization practices for routine vaccination, including in special situations, from Clinical Care Options (CCO)

Robert G. Gish, MD Released: May 9, 2022

Compare current HBV vaccines and learn the best immunization practices for routine vaccination, including in special situations, from Clinical Care Options (CCO)

Robert G. Gish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 9, 2022 Expired: May 8, 2023

Video Chapters


Provided by the University of Cincinnati, in collaboration with ASCP and GAPNA.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Sanofi US

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings